XML 24 R12.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Investments and other assets | 12 Months Ended
--- | ---
Dec. 31, 2019
Investments, All Other Investments [Abstract] |
Investments and other assets | Investments and other assets Our investments and other assets consisted of the following as of December 31, 2019 and 2018 (in thousands):
| Dec. 31,
| 2019 |  | 2018
Cash value life insurance | $ | 52,462 |  |  | $ | 50,452 |
Equity method investments | 27,650 |  |  | 41,420 |
Other equity investments | 32,383 |  |  | 24,497 |
Deferred debt issuance costs | 10,921 |  |  | 9,350 |
Other long-term assets | 21,853 |  |  | 17,746 |
Total | $ | 145,269 |  |  | $ | 143,465 |
Cash value life insurance: We are the beneficiary of life insurance policies on the lives of certain employees/retirees, which are recorded at their cash surrender value as determined by the insurance carrier. These policies are utilized as a partial funding source for deferred compensation and other non-qualified employee retirement plans. Gains and losses on these investments are included in Other non-operating items, net within our Consolidated Statement of Income and were not material for all periods presented. Equity method investments: We hold equity method investments. Our largest equity method investment is our ownership in CareerBuilder, of which we own approximately 17% (or approximately 10% on a fully-diluted basis), which has an investment balance of $7.9 million as of December 31, 2019 and $12.4 million as of December 31, 2018. Our ownership stake provides us with two seats on CareerBuilder’s board of directors. As a result, we concluded that we have significant influence over CareerBuilder and therefore account for our interest using the equity method of accounting. In the first quarter of 2019, we sold our investment in Captivate, which had been accounted for as an equity method investment, for $16.2 million, which resulted in a pre-tax gain of $12.2 million (after-tax gain of $9.2 million). This gain was recorded in Equity income in unconsolidated investments, net within the Consolidated Statement of Income and Statement of Cash Flows. Other equity investments: Represent investments in non-public businesses that do not have readily determinable pricing, and for which we do not have control or do not exert significant influence. These investments are recorded at cost less impairments, if any, plus or minus changes in observable prices for those investments. During 2019, we recognized a gain of $5.9 million in Other non-operating items, net in the Consolidated Statements of Income, based on observable price changes for certain equity investments without readily determinable fair value. Deferred debt issuance costs: These costs consist of amounts paid to lenders related to our revolving credit facility. Debt issuance costs paid for our term debt and unsecured notes are accounted for as a reduction in the debt obligation.

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for investments and other noncurrent assets. + References No definition available. + Details
Name: | us-gaap_InvestmentsAndOtherNoncurrentAssetsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration